AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium

Neuro Oncol. 2020 Jun 9;22(6):886-888. doi: 10.1093/neuonc/noaa045.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Artificial Intelligence
  • Biomarkers
  • Humans
  • Medical Oncology*
  • Precision Medicine*
  • Prognosis

Substances

  • Biomarkers